 |
|
|
|
In the NewsSpecialist recognized 20 years later for first
endovascular technique
The first endovascular treatment of an
abdominal aortic aneurysm (EVAR) in North America was
celebrated during the 39th annual VEITH symposium, a
conference supporting vascular surgeons and other
specialists recognizing new developments in clinical
practice and research. The procedure was performed Nov.
23, 1992. Schönholz was joined by the procedure team
of Juan Parodi, M.D., Frank J. Veith, M.D., Michael L.
Marin, M.D., and Jacob Cynamon, M.D. The story of how this technique was developed and adopted in the U.S. is a testament to the forward thinking and collaborative investigators who sought to expand the treatment options available to their patients. Read the whole story here. Celebrating the 20th
Anniversary of the 1st EVAR Procedure
November 2012  Dr. Claudio Schonholz is seen here,
2nd from left in front, participating in the first EVAR
procedure in 1992.On November 23, 1992 Dr. Claudio Schonholz along with other luminaries in the field of Vascular Surgery and Interventional Radiology such as Dr. Juan Parodi, Dr. Frank Veith, Dr. Michael Marin and Dr. Jacob Cynamon, participated in the first endovascular treatment of an abdominal aortic aneurysm at Montefiore Hospital in New York. The 20th anniversary of this pioneering moment was celebrated by specialty physicians from around the country and the world at the recent VEITH Symposium in New York in November. We congratulate Dr. Schonholz and his colleagues for this milestone!
 Published in Renal & Urology News at http://www.renalandurologynews.com/ March 29, 2012 A radiofrequency (RF) wire technique appears to be a safe alternative for managing benign chronic central venous occlusions when conventional techniques have failed, according to findings presented at the 37th Annual Scientific Meeting of the Society of Interventional Radiology. "We have been the pioneers on this," stated study investigator Marcelo Guimaraes, MD, Associate Professor of Vascular and Interventional Radiolgy at the Medical Unviersity o fSouth Carolina in Charleston. "We have been doing this now for four years and probably this is the largest experience in the world with this procedure. We only treat symptomatic patients or patients who are on dialysis and the AV [arteriovenous] graft or fistula is showing malfunction." Read the entire article.  Abdominal Aortic Aneurysm (AAA) - Andrew's Story When Andrew Chambers began to feel excruciating pain, he had no idea that a cataloupe sized abdominal aortic aneurysm was the cause. It had ruptured and was leaking. Emergency doctors in Myrtle Beach had him flown by helicopter to the MUSC Heart and Vascular Center where a team of vascular surgeons and interventional radiologists was assembled and waiting for his arrival. To hear his story and find out how MUSC's technology is helping change what's possible for patients with life-threatening issues like AAA, click on the photo above. Watch the video. Next-generation EVAR devices hold promise Published in Vascular News at http://www.cxvascular.com  January
19, 2012 The Tuesday morning
session "Extreme EVAR and TEVAR: Exploring the
limits of endovascular technology" was full of
“great cutting-edge stuff,” said course director
Shaun Samuels. “It is where we would all like to
be in a few years.”Claudio J Schonholz, began the session with a discussion of chimneys, snorkels and periscopes. These techniques are an alternative to stent grafts with fenestrations or branches, and preserve blood flow to side branches in the sealing zones of aortic stent grafts.“ They were developed by the same people that pioneered fenestration and branch grafting technology,” Schonholz said. Read the entire article. Type in EVAR devices hold promise in search field when you get to website if the link doesn't take you directly to the article.
 New
outpatient
VIR clinic offers conveniencePublished in the Catalyst April 8, 2011 by Cindy Abole, Public Relations Pictured: VIR clinic physician Dr. Marcelo Guimaraes checks the lungs of patient Gail Kemp. A month ago, Lisa Miles struggled to do simple
chores around her country home in Cordova, just miles
outside of Orangeburg. Years earlier when Miles
underwent a successful double bypass heart surgery at
MUSC she entrusted the physicians and staff for her
specialized care. Recently, Miles returned to MUSC to
help manage other medical complications and was guided
to the care of physicians at Ashley River Tower's new
Vascular Interventional Radiology (VIR) outpatient
clinic. The VIR clinic was established to provide
quality comprehensive medical care and expertise in a
visible and accessible location for patients. The
weekly clinic, located in the same first-floor
clinical area shared by cardiology, vascular and
gastrointestinal surgery, opened its doors last
November. Since 1993, the division established
themselves by performing about 1,300
minimally-invasive procedures. Today, thanks to
advances in technology and patient outcomes, that
number has almost quadrupled to more than 7,500
specialty procedures in 2009. Read
the
entire article.
MUSC One of First in Nation to Implant New Stent System in Artery Released by MUSC and published on Charleston Life Sciences website CHARLESTON, SC (March
15, 2011) - The Medical University of South
Carolina (MUSC) became one of the first centers
nationwide to implant the MISAGO(tm)
Self-expanding Stent System as part of the
Occlusive/Stenotic Peripheral artery
REvascularization StudY (OSPREY) in the U.S.,
which will evaluate the safety and efficacy of the
MISAGO(tm) Peripheral Self-expanding Stent System
for use in the superficial femoral artery (SFA),
the main blood vessel that supplies blood to the
legs and feet. Read
the entire article.
First successful cases of patients treated using Gore C3 delivery system Published in Vascular News at http://www.cxvascular.com Friday, 14 Jan 2011 Gore reported the first clinical uses of the Gore C3 delivery system to deploy the Gore Excluder AAA endoprosthesis as a minimally invasive treatment for patients suffering from an abdominal aortic aneurysm (AAA). The device received approval from the FDA at the beginning of January 2011. The first procedures were successfully performed by vascular surgeons and interventionalists at medical centers around the USA few days later after its approval. This new technology allows physicians to position the device to the specific anatomy of each individual patient. Read the entire article. Type in Gore C3 delivery system in search field when you get to website. Flow reversal or filter devices: Experts debate the merits of two approaches in carotid stenting Published in heartwire at www.theheart.org by Michael O'Riordan  Miami Beach, FL - Filters or flow reversal, that was the question, posed before two experts speaking on cerebral protection during carotid stenting procedures, a debate that that took place today at the International Symposium on Endovascular Therapy (ISET) 2011 meeting in Miami Beach, FL. Drs Claudio Schonholz (Medical University of South Carolina, Charleston) and Nelson "Nick" Hopkins(State University of New York, Buffalo) argued for flow-reversal/flow-exclusive devices and filtration systems, respectively, with Schonholz making the argument that filters capture only a fraction of the embolized particles that break off during the stenting procedure.  Islet cell transplant offers promising lifeline Published in the Catalyst, February 4, 2011 by Dawn Brazell Public Relations MUSC holds the distinction of being the second busiest autologous islet cell transplant center in the country, behind the University of Minnesota, which started doing the procedure in the 1970s. MUSC, the only place in the state to offer the procedure, treated its first patient March 2009, and performs about 25 cases a year to treat chronic pancreatitis. Read the entire article or watch a video about the procedure. Pictured: Monica Mumme, Hedy Fagan and Dr. Renan Uflacker. Legs for Life: Another Successful Year! Pictured: Tom Leuck, Radiology resident Dr. Emily Zerwas and Dr. Renan Uflacker discuss results during the Legs for Life event. On Saturday, October 3,
2009 the Heart and
Following this stage,
patients with positive results were seen on an
individual basis by the physicians to discuss the
patients’ case in detail. Dr. Guimarães
pointed out that during this entire process,
“Orientation for risk factors management and annual
revision with a primary care doctor were among the
several things that we tried to target during the
screening. The patients with indication for further
evaluation (or a positive screening) will have their
primary care physician contacted in order to discuss
the referral of these patients to MUSC for a more
detailed investigation and treatment, if indicated”.
Natalie Ankney, manager
of the Ashley River Tower Heart and
During this year’s
Legs for Life, 107 patients had normal results, 21
patients had abnormal results and there were 11
referrals for MUSC. Thank you to everyone
involved in this very successful Legs for Life! 
MUSC
Wellness Run & Walk On September 19, the
Pictured, from left to right: Monica
Mumme, Dr. Bayne Selby, Marcus Schönholz, John
Furtek, Dr. Claudio Schönholz, Brooke Bently,
Aaron McConnell, Amy Johnson and Chris Erikson. (Reprinted from MUSC Radiology Department Newsletter, October 2009.)
New MUSC cellular therapy center expands, improves transplants Published in the Catalyst, March 27, 2009  A new and unique facility at MUSC uses a patient's own cells to perform life-saving procedures while erasing the problem of rejection and reducing the need for full organ transplants. The Center for Cellular Therapy (CCT) is the first center in South Carolina to perform an autologous islet cell transplant for chronic pancreatitis. The first patient, a woman from Aiken, underwent a CCT procedure on March 9 that enabled insulin-producing islet cells to be removed from her diseased pancreas and transplanted into her liver. Dr. Renan P. Uflacker
prepares to reintroduce the patient’s own insulin-producing
cells
into her liver using a catheter and flouroscopy via
the portal vein.
Radiology Docs make
great showing at MUSC 2 Mile Wellness Run & Walk
Dr. Curry placed first in
her age group with a time of 15:50, even though she
was feeling a bit “under the weather” just before the
race! Both Dr. Guimaraes
(running time: 14:10) and Dr. Selby (running time:
13:26) placed second in their age groups. Congratulations
to
them
and
to
everyone
who
participated. (Reprinted from MUSC
Radiology Department Newsletter, October 2008.) Listen to the new podcast interviews with Dr. Renan Uflacker on Radiologic Treatments for Primary and Metastatic Liver Cancer and Use of Stents to Repair Carotid Artery Blockage. Listen to the podcast interviews with Dr. Bayne Selby on Interventional Radiology, Fibroids and Uterine Artery Embolization, and Varicose Veins. Also listen to a patient of Dr. Uflacker's talk about receiving chemoembolization and radio frequency ablations to treat his liver cancer. Fibroid patients need
personalized care MUSC First in State to Monitor
'Silent Killer' Innovative Treatments
for Liver Cancer Available State
of
the Art for the State of Your Heart Scanner
provides
non-invasive diagnosis
|
